Published in Ann Intensive Care on June 18, 2012
Statins for Acutely Injured Lungs From Sepsis (SAILS) | NCT00979121
High-dose Simvastatin for Aneurysmal Subarachnoid Haemorrhage (HDS-SAH) | NCT01077206
Statins and Cerebral Blood Flow in Subarachnoid Hemorrhage (SAH) | NCT00795288
New treatments for influenza. BMC Med (2012) 0.95
Sepsis outcomes in patients receiving statins prior to hospitalization for sepsis: comparison of in-hospital mortality rates between patients who received atorvastatin and those who received simvastatin. Ann Intensive Care (2015) 0.79
Systematic review of statins in sepsis: There is no evidence of dose response. Indian J Crit Care Med (2016) 0.77
Pharmacological interventions in acute respiratory distress syndrome. Ann Intensive Care (2013) 0.77
Prescribing Patterns of Drugs in Acute Respiratory Distress Syndrome (ARDS): An Observational Study. J Clin Diagn Res (2015) 0.75
Effect of Statins on the Mortality of Bacteremic Patients: A Systematic Review and Meta-analysis of Clinical Trials. N Am J Med Sci (2016) 0.75
Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med (2000) 48.03
Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med (2008) 43.36
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) Lancet (1994) 40.72
Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med (1995) 28.35
The pathophysiology and treatment of sepsis. N Engl J Med (2003) 21.67
Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science (2006) 18.74
Methylprednisolone infusion in early severe ARDS: results of a randomized controlled trial. Chest (2007) 7.49
Clinical practice. Vitamin D insufficiency. N Engl J Med (2011) 6.84
Septic shock. Lancet (2005) 6.67
Influenza and COPD mortality protection as pleiotropic, dose-dependent effects of statins. Chest (2007) 4.96
Matrilysin shedding of syndecan-1 regulates chemokine mobilization and transepithelial efflux of neutrophils in acute lung injury. Cell (2002) 4.89
Statins and sepsis in patients with cardiovascular disease: a population-based cohort analysis. Lancet (2006) 4.42
The safety of statins in clinical practice. Lancet (2007) 3.85
Adherence to lipid-lowering therapy and the use of preventive health services: an investigation of the healthy user effect. Am J Epidemiol (2007) 3.82
Tidal volume reduction in patients with acute lung injury when plateau pressures are not high. Am J Respir Crit Care Med (2005) 3.69
Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site. Nat Med (2001) 3.69
Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors. Arterioscler Thromb Vasc Biol (2001) 3.65
Statins and outcomes in patients admitted to hospital with community acquired pneumonia: population based prospective cohort study. BMJ (2006) 3.62
Withdrawal of statins increases event rates in patients with acute coronary syndromes. Circulation (2002) 3.48
Epidemiology of severe sepsis occurring in the first 24 hrs in intensive care units in England, Wales, and Northern Ireland. Crit Care Med (2003) 3.39
Adult-population incidence of severe sepsis in Australian and New Zealand intensive care units. Intensive Care Med (2004) 3.30
Preadmission use of statins and outcomes after hospitalization with pneumonia: population-based cohort study of 29,900 patients. Arch Intern Med (2008) 3.10
The effect of statins on mortality in patients with bacteremia. Clin Infect Dis (2001) 3.02
Statins and sepsis: multiple modifications at multiple levels. Lancet Infect Dis (2007) 2.84
Normal responses to injury prevent systemic inflammation and can be immunosuppressive. Am J Respir Crit Care Med (2001) 2.82
Statin therapy is associated with fewer deaths in patients with bacteraemia. Intensive Care Med (2005) 2.81
Decreased antioxidant status and increased lipid peroxidation in patients with septic shock and secondary organ dysfunction. Crit Care Med (1995) 2.52
Simvastatin decreases lipopolysaccharide-induced pulmonary inflammation in healthy volunteers. Am J Respir Crit Care Med (2009) 2.52
Alterations in vitamin D status and anti-microbial peptide levels in patients in the intensive care unit with sepsis. J Transl Med (2009) 2.49
Statin adherence and risk of accidents: a cautionary tale. Circulation (2009) 2.47
The effect of statin therapy on infection-related mortality in patients with atherosclerotic diseases. Crit Care Med (2007) 2.42
Prehospital statin and aspirin use and the prevalence of severe sepsis and acute lung injury/acute respiratory distress syndrome. Crit Care Med (2011) 2.40
Long-term mortality and medical care charges in patients with severe sepsis. Crit Care Med (2003) 2.39
Effect of statin treatment on short term mortality after pneumonia episode: cohort study. BMJ (2011) 2.32
HMG-CoA reductase inhibitor simvastatin profoundly improves survival in a murine model of sepsis. Circulation (2004) 2.30
Do statins improve outcomes and reduce the incidence of vasospasm after aneurysmal subarachnoid hemorrhage: a meta-analysis. Stroke (2008) 2.23
Continuation of statin therapy in patients with presumed infection: a randomized controlled trial. Am J Respir Crit Care Med (2010) 2.21
Simvastatin inhibits inflammatory properties of Staphylococcus aureus alpha-toxin. Circulation (2002) 2.20
The effect of prior statin use on 30-day mortality for patients hospitalized with community-acquired pneumonia. Respir Res (2005) 2.18
Simvastatin lowers C-reactive protein within 14 days: an effect independent of low-density lipoprotein cholesterol reduction. Circulation (2002) 2.17
Statin use and mortality within 180 days after bacteremia: a population-based cohort study. Crit Care Med (2006) 2.16
Prior statin use is associated with improved outcomes in community-acquired pneumonia. Am J Med (2008) 2.14
Simvastatin attenuates vascular leak and inflammation in murine inflammatory lung injury. Am J Physiol Lung Cell Mol Physiol (2005) 2.13
Statin treatment after onset of sepsis in a murine model improves survival. Circulation (2005) 2.08
Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev (2007) 2.08
Anti-inflammatory therapies to treat sepsis and septic shock: a reassessment. Crit Care Med (1997) 2.00
Statins decrease Toll-like receptor 4 expression and downstream signaling in human CD14+ monocytes. Arterioscler Thromb Vasc Biol (2005) 1.95
The effect of statins on mortality from severe infections and sepsis: a systematic review and meta-analysis. J Crit Care (2010) 1.95
Cellular antioxidant effects of atorvastatin in vitro and in vivo. Arterioscler Thromb Vasc Biol (2002) 1.89
Statin therapy prior to ICU admission: protection against infection or a severity marker? Intensive Care Med (2005) 1.86
Structural basis for LFA-1 inhibition upon lovastatin binding to the CD11a I-domain. J Mol Biol (1999) 1.83
Impact of statins and angiotensin-converting enzyme inhibitors on mortality of subjects hospitalised with pneumonia. Eur Respir J (2007) 1.80
Understanding the potential role of statins in pneumonia and sepsis. Crit Care Med (2011) 1.77
Simvastatin in aneurysmal subarachnoid haemorrhage (STASH): a multicentre randomised phase 3 trial. Lancet Neurol (2014) 1.73
The impact of statins, ACE inhibitors and gastric acid suppressants on pneumonia mortality in a UK general practice population cohort. Pharmacoepidemiol Drug Saf (2009) 1.69
A randomized clinical trial of hydroxymethylglutaryl- coenzyme a reductase inhibition for acute lung injury (The HARP Study). Am J Respir Crit Care Med (2010) 1.67
Acute lung injury and the acute respiratory distress syndrome in Ireland: a prospective audit of epidemiology and management. Crit Care (2008) 1.64
Effects of methylprednisolone infusion on markers of inflammation, coagulation, and angiogenesis in early acute respiratory distress syndrome. Crit Care Med (2012) 1.64
Statin use was not associated with less vasospasm or improved outcome after subarachnoid hemorrhage. Neurosurgery (2008) 1.63
Statins and the risk of pneumonia: a population-based, nested case-control study. Pharmacotherapy (2007) 1.61
The effects of statin therapy on inflammatory cytokines in patients with bacterial infections: a randomized double-blind placebo controlled clinical trial. Intensive Care Med (2009) 1.61
A role for hydroxy-methylglutaryl coenzyme a reductase in pulmonary inflammation and host defense. Am J Respir Crit Care Med (2004) 1.60
Diffuse alveolar damage--the role of oxygen, shock, and related factors. A review. Am J Pathol (1976) 1.59
Immunomodulatory agents in the treatment of community-acquired pneumonia: a systematic review. J Infect (2011) 1.57
Why immunomodulatory therapies have not worked in sepsis. Intensive Care Med (1999) 1.53
Possible role of increased oxidant stress in multiple organ failure after systemic inflammatory response syndrome. Crit Care Med (2003) 1.53
Simvastatin induces heme oxygenase-1: a novel mechanism of vessel protection. Circulation (2004) 1.52
Cerivastatin improves survival of mice with lipopolysaccharide-induced sepsis. J Pharmacol Exp Ther (2000) 1.49
Plasma antioxidant potential in severe sepsis: a comparison of survivors and nonsurvivors. Crit Care Med (1996) 1.48
Simvastatin reduces vasospasm after aneurysmal subarachnoid hemorrhage: results of a pilot randomized clinical trial. Stroke (2005) 1.44
Current overview of statin-induced myopathy. Am J Med (2004) 1.41
A preliminary study of atorvastatin plasma concentrations in critically ill patients with sepsis. Intensive Care Med (2008) 1.33
Activation and regulation of systemic inflammation in ARDS: rationale for prolonged glucocorticoid therapy. Chest (2009) 1.32
Statin use and risk of community acquired pneumonia in older people: population based case-control study. BMJ (2009) 1.30
The antioxidant defense protein heme oxygenase 1 is a novel target for statins in endothelial cells. Free Radic Biol Med (2004) 1.30
Simvastatin suppresses endotoxin-induced upregulation of toll-like receptors 4 and 2 in vivo. Atherosclerosis (2006) 1.26
Simvastatin decreases nitric oxide overproduction and reverts the impaired vascular responsiveness induced by endotoxic shock in rats. Shock (2004) 1.23
Adenovirus-mediated transfer of heme oxygenase-1 cDNA attenuates severe lung injury induced by the influenza virus in mice. Gene Ther (2001) 1.20
Statin effects on cholesterol micro-domains in brain plasma membranes. Biochem Pharmacol (2003) 1.17
Simvastatin ameliorates injury in an experimental model of lung ischemia-reperfusion. J Thorac Cardiovasc Surg (2003) 1.16
Immunostimulation is a rational therapeutic strategy in sepsis. Novartis Found Symp (2007) 1.15
Association of statin therapy and increased survival in patients with multiple organ dysfunction syndrome. Intensive Care Med (2006) 1.15
Reduction in mortality associated with statin therapy in patients with severe sepsis. Pharmacotherapy (2009) 1.15
Biologic effects of simvastatin in patients with aneurysmal subarachnoid hemorrhage: a double-blind, placebo-controlled randomized trial. J Cereb Blood Flow Metab (2009) 1.08
Statin therapy is associated with decreased mortality in patients with infection. Acad Emerg Med (2009) 1.07
Statins increase thrombomodulin expression and function in human endothelial cells by a nitric oxide-dependent mechanism and counteract tumor necrosis factor alpha-induced thrombomodulin downregulation. Blood Coagul Fibrinolysis (2003) 1.07
Preadmission statin use and one-year mortality among patients in intensive care - a cohort study. Crit Care (2010) 1.07
Rosuvastatin upregulates the antioxidant defense protein heme oxygenase-1. Biochem Biophys Res Commun (2004) 1.06
A randomized, double-blind, placebo-controlled pilot study of simvastatin in aneurysmal subarachnoid hemorrhage. Stroke (2008) 1.06
Effectiveness of statins in reducing the rate of severe sepsis: a retrospective evaluation. Pharmacotherapy (2007) 1.05
Sustained increased cerebral blood flow with prophylactic hypertensive hypervolemic hemodilution ("triple-H" therapy) after subarachnoid hemorrhage. Neurosurgery (1990) 1.03
Fluvastatin treatment inhibits leucocyte adhesion and extravasation in models of complement-mediated acute inflammation. Clin Exp Immunol (2004) 1.00
HMG-CoA reductase inhibitors inhibit inducible nitric oxide synthase gene expression in macrophages. J Biomed Sci (2003) 0.99
Impact of previous statin and angiotensin II receptor blocker use on mortality in patients hospitalized with sepsis. Pharmacotherapy (2007) 0.99
Effects of acute pravastatin treatment on intensity of rescue therapy, length of inpatient stay, and 6-month outcome in patients after aneurysmal subarachnoid hemorrhage. Stroke (2007) 0.96
SSRI and statin use increases the risk for vasospasm after subarachnoid hemorrhage. Neurology (2005) 0.93
Statins are associated with improved outcomes of bloodstream infection in solid-organ transplant recipients. Eur J Clin Microbiol Infect Dis (2009) 0.93
Statins inhibit toll-like receptor 4-mediated lipopolysaccharide signaling and cytokine expression. Pharmacogenet Genomics (2008) 0.92
Microvascular blood flow is altered in patients with sepsis. Am J Respir Crit Care Med (2002) 5.84
Procalcitonin usefulness for the initiation of antibiotic treatment in intensive care unit patients. Crit Care Med (2012) 4.76
Stress hyperglycaemia. Lancet (2009) 3.13
Glucose variability and mortality in patients with sepsis. Crit Care Med (2008) 3.00
Year in review in Intensive Care Medicine 2011: III. ARDS and ECMO, weaning, mechanical ventilation, noninvasive ventilation, pediatrics and miscellanea. Intensive Care Med (2012) 2.52
Goal-directed intraoperative therapy reduces morbidity and length of hospital stay in high-risk surgical patients. Chest (2007) 2.38
When should we add parenteral to enteral nutrition? Lancet (2012) 2.08
Toward understanding tight glycemic control in the ICU: a systematic review and metaanalysis. Chest (2009) 1.83
Clinical review: Consensus recommendations on measurement of blood glucose and reporting glycemic control in critically ill adults. Crit Care (2013) 1.72
Glutamine, a life-saving nutrient, but why? Crit Care Med (2003) 1.70
Diabetic status and the relation of the three domains of glycemic control to mortality in critically ill patients: an international multicenter cohort study. Crit Care (2013) 1.66
Does methylene blue administration to septic shock patients affect vascular permeability and blood volume? Crit Care Med (2002) 1.59
Intensive care unit acquired infection and organ failure. Intensive Care Med (2008) 1.54
Heme oxygenase: a new piece in the glutamine puzzle. Crit Care Med (2005) 1.50
Does aprotinin influence the inflammatory response to cardiopulmonary bypass in patients? J Thorac Cardiovasc Surg (2003) 1.45
Year in review in Intensive Care Medicine 2011. II. Cardiovascular, infections, pneumonia and sepsis, critical care organization and outcome, education, ultrasonography, metabolism and coagulation. Intensive Care Med (2012) 1.39
Moving beyond tight glucose control to safe effective glucose control. Crit Care (2008) 1.33
Insulin-treated diabetes is not associated with increased mortality in critically ill patients. Crit Care (2010) 1.18
Current controversies around tight glucose control in critically ill patients. Curr Opin Clin Nutr Metab Care (2007) 1.17
SAFETY AND EFFICACY OF PERSONALIZED GLYCEMIC CONTROL IN CRITICALLY ILL PATIENTS: A 2 YEAR BEFORE AND AFTER INTERVENTIONAL TRIAL. Endocr Pract (2016) 1.16
Gut failure in the ICU. Semin Respir Crit Care Med (2011) 1.14
Continuous glucose control in the ICU: report of a 2013 round table meeting. Crit Care (2014) 1.13
Organ failure and tight glycemic control in the SPRINT study. Crit Care (2010) 1.12
International recommendations for glucose control in adult non diabetic critically ill patients. Crit Care (2010) 1.09
SAPS 3 admission score: an external validation in a general intensive care population. Intensive Care Med (2008) 1.07
Validation of a model-based virtual trials method for tight glycemic control in intensive care. Biomed Eng Online (2010) 1.06
Glucose, insulin and myocardial ischaemia. Curr Opin Clin Nutr Metab Care (2006) 1.04
An overview of hypoglycemia in the critically ill. J Diabetes Sci Technol (2009) 1.02
Tight glycemic control in critical care--the leading role of insulin sensitivity and patient variability: a review and model-based analysis. Comput Methods Programs Biomed (2010) 1.02
Diarrhoea in the critically ill. Curr Opin Crit Care (2006) 1.02
Impact of diagnostic criteria on the incidence of ventilator-associated pneumonia. Chest (2015) 0.99
Mild hypoglycemia is strongly associated with increased intensive care unit length of stay. Ann Intensive Care (2011) 0.98
Nutrition disorders during acute renal failure and renal replacement therapy. JPEN J Parenter Enteral Nutr (2011) 0.96
What makes tight glycemic control tight? The impact of variability and nutrition in two clinical studies. J Diabetes Sci Technol (2010) 0.95
Variability of insulin sensitivity during the first 4 days of critical illness: implications for tight glycemic control. Ann Intensive Care (2012) 0.94
Accuracy and limitations of continuous glucose monitoring using spectroscopy in critically ill patients. Ann Intensive Care (2014) 0.93
Year in review in Intensive Care Medicine 2009. Part III: mechanical ventilation, acute lung injury and respiratory distress syndrome, pediatrics, ethics, and miscellanea. Intensive Care Med (2010) 0.93
First pilot trial of the STAR-Liege protocol for tight glycemic control in critically ill patients. Comput Methods Programs Biomed (2011) 0.92
Tight glucose control and hypoglycemia. Crit Care Med (2008) 0.91
Trial of the route of early nutritional support in critically ill adults. N Engl J Med (2015) 0.91
Steps for the implementation and validation of tight glucose control. Intensive Care Med (2006) 0.91
Glycemic control in the intensive care unit and during the postoperative period. Anesthesiology (2011) 0.90
Energy estimation and measurement in critically ill patients. JPEN J Parenter Enteral Nutr (2013) 0.90
Year in review in Intensive Care Medicine 2009: I. Pneumonia and infections, sepsis, outcome, acute renal failure and acid base, nutrition and glycaemic control. Intensive Care Med (2010) 0.89
Restoring normoglycaemia: not so harmless. Crit Care (2008) 0.89
Monocyte CD40 expression in severe sepsis. Shock (2003) 0.89
Reduced cortisol metabolism during critical illness. N Engl J Med (2013) 0.88
Is it time for implementation of tight glycaemia control by intensive insulin therapy in every ICU? Crit Care (2006) 0.86
Position paper of the ESICM Working Group on Nutrition and Metabolism. Metabolic basis of nutrition in intensive care unit patients: ten critical questions. Intensive Care Med (2002) 0.86
Antioxidant therapy in intensive care. Curr Opin Crit Care (2003) 0.86
Year in review in Intensive Care Medicine 2012: I. Neurology and neurointensive care, epidemiology and nephrology, biomarkers and inflammation, nutrition, experimentals. Intensive Care Med (2012) 0.84
Is parenteral nutrition guilty? Intensive Care Med (2003) 0.84
Gut mucosal damage during endotoxic shock is due to mechanisms other than gut ischemia. J Appl Physiol (1985) (2003) 0.83
Effects of dobutamine on gut mucosal nitric oxide production during endotoxic shock in rabbits. Med Sci Monit (2009) 0.83
A comparison among portal lactate, intramucosal sigmoid Ph, and deltaCO2 (PaCO2 - regional Pco2) as indices of complications in patients undergoing abdominal aortic aneurysm surgery. Anesth Analg (2004) 0.83
Combination therapy versus monotherapy: a randomised pilot study on the evolution of inflammatory parameters after ventilator associated pneumonia [ISRCTN31976779]. Crit Care (2006) 0.83
Year in review 2013: Critical Care--metabolism. Crit Care (2014) 0.82
Tight blood glucose control: a recommendation applicable to any critically ill patient? Crit Care (2004) 0.82
Year in review in Intensive Care Medicine 2010: III. ARDS and ALI, mechanical ventilation, noninvasive ventilation, weaning, endotracheal intubation, lung ultrasound and paediatrics. Intensive Care Med (2011) 0.81
Biomarkers of oxidative stress in critically ill patients: what should be measured, when and how? Curr Opin Clin Nutr Metab Care (2006) 0.81
Year in review in Intensive Care Medicine 2010: II. Pneumonia and infections, cardiovascular and haemodynamics, organization, education, haematology, nutrition, ethics and miscellanea. Intensive Care Med (2011) 0.81
Pneumonia-induced sepsis and gut injury: effects of a poly-(ADP-ribose) polymerase inhibitor. J Surg Res (2005) 0.80
Tight glucose control: should we move from intensive insulin therapy alone to modulation of insulin and nutritional inputs? Crit Care (2008) 0.79
Intensive insulin therapy to control hyperglycemia in the critically ill: a look back at the evidence shapes the challenges ahead. Crit Care (2010) 0.79
REDOXs: important answers, many more questions raised! JPEN J Parenter Enteral Nutr (2013) 0.79
Are prospective cohort studies an appropriate tool to answer clinical nutrition questions? Curr Opin Clin Nutr Metab Care (2013) 0.79
Arginine and sepsis: a question of the right balance? Crit Care Med (2011) 0.79
Second pilot trials of the STAR-Liege protocol for tight glycemic control in critically ill patients. Biomed Eng Online (2012) 0.79
Year in review in Intensive Care Medicine 2012. II: Pneumonia and infection, sepsis, coagulation, hemodynamics, cardiovascular and microcirculation, critical care organization, imaging, ethics and legal issues. Intensive Care Med (2013) 0.78
Year in review in Intensive Care Medicine 2012: III. Noninvasive ventilation, monitoring and patient-ventilator interactions, acute respiratory distress syndrome, sedation, paediatrics and miscellanea. Intensive Care Med (2013) 0.78
Pancreatic cellular injury after cardiac surgery with cardiopulmonary bypass: frequency, time course and risk factors. Shock (2007) 0.78
Year in review in Intensive Care Medicine 2010: I. Acute renal failure, outcome, risk assessment and ICU performance, sepsis, neuro intensive care and experimentals. Intensive Care Med (2011) 0.78
Nitroglycerin for septic shock. Lancet (2003) 0.78
The long way of biomarkers: from bench to bedside. Intensive Care Med (2010) 0.77
The use of protocols for nutritional support is definitely needed in the intensive care unit. Crit Care Med (2004) 0.77
Glycemic control and nutrition. JPEN J Parenter Enteral Nutr (2011) 0.76
Disorder of osmoregulation as a new pathogenetic mechanism of septic shock? Crit Care Med (2010) 0.76
Methylene blue: an old-timer or a compound ready for revival? Crit Care Med (2006) 0.76
Year in review in Intensive Care Medicine 2011: I. Nephrology, epidemiology, nutrition and therapeutics, neurology, ethical and legal issues, experimentals. Intensive Care Med (2012) 0.75
Tight glucose control in critically ill adults. JAMA (2008) 0.75
In vivo assessment of oxidative stress: a continuing challenge. Crit Care Med (2008) 0.75
Methylene blue as the future protecting agent for ischemic brain injury? Crit Care Med (2010) 0.75
Nutrition therapy for acute respiratory distress syndrome. JPEN J Parenter Enteral Nutr (2008) 0.75
Novel insights into the effects of inducible nitric oxide synthase inhibition during sepsis. Crit Care Med (2008) 0.75
Year in review 2009: Critical Care--metabolism. Crit Care (2010) 0.75
Corticosteroids and septic shock: a new episode of a never-ceasing story? Crit Care Med (2008) 0.75
Avoiding underfeeding in severely ill patients - Authors' reply. Lancet (2013) 0.75
Hyperglycemia-related mortality in critically ill patients varies with admission diagnosis. Crit Care Med (2010) 0.75
Year in review in Intensive Care Medicine 2009: II. Neurology, cardiovascular, experimental, pharmacology and sedation, communication and teaching. Intensive Care Med (2010) 0.75
Management and knowledge of enteral nutrition in intensive care units in a city in Belgium. Nutr Clin Pract (2002) 0.75
Oral Nitrate Increases Microvascular Reactivity and the Number of Visible Perfused Microvessels in Healthy Volunteers. J Vasc Res (2017) 0.75
Is There a Role for Enterohormones in the Gastroparesis of Critically Ill Patients? Crit Care Med (2017) 0.75
Uncontrolled bleeding of the gastrointestinal tract. Curr Opin Crit Care (2017) 0.75
ESPEN disease-specific guideline framework. Clin Nutr (2011) 0.75